Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

Predictors of Calf Arterial Compliance in Male Veterans With Psychiatric Diagnoses.

Koola MM, Sorkin JD, Fargotstein M, Brown WV, Cuthbert B, Hollis J, Raines JK, Duncan EJ.

Prim Care Companion CNS Disord. 2016 Jun 9;18(3). doi: 10.4088/PCC.15m01880.

3.

Associations between measures of vascular structure and function and systemic circulating blood markers in humans.

Cotie LM, Currie KD, McGill GM, Cameron AJ, McFadden AS, Phillips SM, MacDonald MJ.

Physiol Rep. 2016 Sep;4(18). pii: e12982.

4.

The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis.

Mirsaeidi M, Omar HR, Ebrahimi G, Campos M.

Int J Hypertens. 2016;2016:2402515. doi: 10.1155/2016/2402515.

5.

Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia?

Koola MM, Raines JK, Hamilton RG, McMahon RP.

Curr Psychiatr. 2016 May;15(5):52-57. No abstract available.

6.

Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation.

Batumalaie K, Amin MA, Murugan DD, Sattar MZ, Abdullah NA.

Sci Rep. 2016 Jun 2;6:27236. doi: 10.1038/srep27236.

7.

Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.

Li HY, Lin HA, Nien FJ, Wu VC, Jiang YD, Chang TJ, Kao HL, Lin MS, Wei JN, Lin CH, Shih SR, Hung CS, Chuang LM.

PLoS One. 2016 Feb 4;11(2):e0147981. doi: 10.1371/journal.pone.0147981.

8.

Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.

Shehata M, Fayez G, Nassar A.

Tex Heart Inst J. 2015 Dec 1;42(6):528-36. doi: 10.14503/THIJ-14-4891.

9.

Plasma Inflammatory Markers and the Risk of Developing Hypertension in Men.

Sesso HD, Jiménez MC, Wang L, Ridker PM, Buring JE, Gaziano JM.

J Am Heart Assoc. 2015 Sep 21;4(9):e001802. doi: 10.1161/JAHA.115.001802.

10.

Differential Telomere Shortening in Blood versus Arteries in an Animal Model of Type 2 Diabetes.

Tajbakhsh S, Aliakbari K, Hussey DJ, Lower KM, Donato AJ, Sokoya EM.

J Diabetes Res. 2015;2015:153829. doi: 10.1155/2015/153829.

12.

Association of C-Reactive Protein and Metabolic Disorder in a Chinese Population.

Sun M, Zhang L, Chen S, Liu X, Shao X, Zou H.

Int J Environ Res Public Health. 2015 Jul 17;12(7):8228-42. doi: 10.3390/ijerph120708228.

13.

High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study.

Effoe VS, Correa A, Chen H, Lacy ME, Bertoni AG.

Diabetes Care. 2015 Sep;38(9):1694-700. doi: 10.2337/dc15-0221.

14.

Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.

Adegunsoye A, Balachandran J.

Mediators Inflamm. 2015;2015:510105. doi: 10.1155/2015/510105. Review.

15.

Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis.

Kim KW, Kim BM, Moon HW, Lee SH, Kim HR.

Arthritis Res Ther. 2015 Mar 4;17:41. doi: 10.1186/s13075-015-0563-z.

16.

C-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetes.

Peng D, Wang J, Zhang R, Tang S, Jiang F, Chen M, Yan J, Sun X, Wang T, Wang S, Bao Y, Hu C, Jia W.

BMC Endocr Disord. 2015 Mar 2;15:8. doi: 10.1186/s12902-015-0006-5.

17.

Arginine and citrulline and the immune response in sepsis.

Wijnands KA, Castermans TM, Hommen MP, Meesters DM, Poeze M.

Nutrients. 2015 Feb 18;7(3):1426-63. doi: 10.3390/nu7031426. Review.

19.

Fcγ receptors and ligands and cardiovascular disease.

Tanigaki K, Sundgren N, Khera A, Vongpatanasin W, Mineo C, Shaul PW.

Circ Res. 2015 Jan 16;116(2):368-84. doi: 10.1161/CIRCRESAHA.116.302795. Review.

20.

Role of the endothelium in the metabolic syndrome: IIB or not IIB.

Shaul PW.

Am J Med Sci. 2015 Jan;349(1):3-5. doi: 10.1097/MAJ.0000000000000402. No abstract available.

Items per page

Supplemental Content

Support Center